|
1
|
Burgess JG: New and emerging analytical
techniques for marine biotechnology. Curr Opin Biotechnol.
23:29–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin X, Liu M, Hu C and Liao DJ: Targeting
cellular proapoptotic molecules for developing anticancer agents
from marine sources. Curr Drug Targets. 11:708–715. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abraham I, El Sayed K, Chen ZS and Guo H:
Current status on marine products with reversal effect on cancer
multidrug resistance. Mar Drugs. 10:2312–2321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta SC, Kim JH, Prasad S and Aggarwal
BB: Regulation of survival, proliferation, invasion, angiogenesis,
and metastasis of tumor cells through modulation of inflammatory
pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leal MC, Madeira C, Brandão CA, Puga J and
Calado R: Bioprospecting of marine invertebrates for new natural
products-a chemical and zoogeographical perspective. Molecules.
17:9842–9854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu GP, Yuan J, Sun L, She ZG, Wu JH, Lan
XJ, Zhu X, Lin YC and Chen SP: Statistical research on marine
natural products based on data obtained between 1985 and 2008. Mar
Drugs. 9:514–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li GY, Yu XM, Zhang HW, Zhang B, Wang CB,
Xin YC, Yang CZ, Zhou RX and Wang LX: Haishengsu as an adjunct
therapy to conventional chemotherapy in patients with non-small
cell lung cancer: A pilot randomized and placebo-controlled
clinical trial. Complement Ther Med. 17:51–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu JZ, Chen SG, Zhang B, Wang CB, Zhao
XW, Li GY and Wang LX: Effect of haishengsu as an adjunct therapy
for patients with advanced renal cell cancer: A randomized and
placebo-controlled clinical trial. J Altern Complement Med.
15:1127–1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao MQ, Han YT, Zhu L, Chen SG, Hong ZY
and Wang CB: Cytotoxicity of natural extract from Tegillarca
granosa on ovarian cancer cells is mediated by multiple
molecules. Clin Invest Med. 32:E368–E375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu HP, Gao ZH, Cui SX, Xue X, Hou CY,
Jiang ZM, Zhao CR, Wang CB, Chen SG and Qu XJ: Haishengsu, a
protein from shellfish Tegillarca L. granosa,
inhibits the growth and the activity of matrix metalloproteinases-2
and −9 in human lung carcinoma. Food Biophysics. 6:390–396. 2011.
View Article : Google Scholar
|
|
11
|
Li GY, Liu JZ, Zhang B, Yang M, Chen SG,
Hou M and Wang LX: Tegillarca granosa extract Haishengsu
(HSS) suppresses expression of mdr1, BCR/ABL and sorcin in
drug-resistant K562/ADM tumors in mice. Adv Med Sci. 58:112–117.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li GY, Liu JZ, Chen SG, Zhang B, Wang CB
and Wang LX: Tegillarca granosa extract Haishengsu inhibits
the expression of p-glycoprotein and induces apoptosis in
drug-resistant K562/ADM cells. Pharm Biol. 48:529–533. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu W, Kong X, Jiang C, Liu X and Xu L: The
anti-tumor effect of a polypeptide extracted from Tegillarca
granosa Linnaeus on renal metastatic tumor OS-RC-2 cells. Arch
Med Sci. 11:849–855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li GY, Liu JZ, Chen SG, Wang CB, Bin Z and
Wang LX: Effect of a seashell protein Haishengsu on the
immunological function of mice with Ehrlich ascites tumor.
Immunopharmacol Immunotoxicol. 31:669–674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Han Y, Zhan S, Wang C and Chen S:
Tegillarca granosa extract Haishengsu induces apoptosis in
human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling
pathways. Cell Biochem Biophys. 71:837–844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hajra KM and Liu JR: Apoptosome
dysfunction in human cancer. Apoptosis. 9:691–704. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fesik SW: Promoting apoptosis as a
strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khodarev NN, Sokolova IA and Vaughan ATM:
Mechanisms of induction of apoptotic DNA fragmentation. Int J
Radiat Biol. 73:455–467. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han YT, Chen XH, Gao H, Ye JL and Wang CB:
Physcion inhibits the metastatic potential of human colorectal
cancer SW620 cells in vitro by suppressing the transcription factor
SOX2. Acta pharmacol Sin. 37:264–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lazebnik YA, Kaufmann SH, Desnoyers S,
Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase
by a proteinase with properties like ice. Nature. 371:346–347.
1994. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alves RC, Alves D, Guz B, Matos C, Viana
M, Harriz M, Terrabuio D, Kondo M, Gampel O and Polletti P:
Advanced hepatocellular carcinoma. Review of targeted molecular
drugs. Ann Hepatol. 10:21–27. 2011.PubMed/NCBI
|
|
23
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Newman DJ, Cragg GM and Snader KM: Natural
products as sources of new drugs over the period 1981–2002. J Nat
Prod. 66:1022–1037. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Indran IR, Tufo G, Pervaiz S and Brenner
C: Recent advances in apoptosis, mitochondria and drug resistance
in cancer cells. Biochim Biophys Acta. 1807:735–745. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dai JJ, Niu YF, Wu CF, Zhang SH and Zhang
DF: Both death receptor and mitochondria mediated apoptotic
pathways participated the occurrence of apoptosis in porcine
vitrified mii stage oocytes. Cryo Letters. 37:129–136.
2016.PubMed/NCBI
|
|
28
|
Yoo KH, Park JH, Lee DK, Fu YY, Baek NI
and Chung IS: Pomolic acid induces apoptosis in SK-OV-3 human
ovarian adenocarcinoma cells through the mitochondrial-mediated
intrinsic and death receptor-induced extrinsic pathways. Oncol
Lett. 5:386–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qi F, Li A, Inagaki Y, Xu H, Wang D, Cui
X, Zhang L, Kokudo N, Du G and Tang W: Induction of apoptosis by
cinobufacini preparation through mitochondria- and Fas-mediated
caspase-dependent pathways in human hepatocellular carcinoma cells.
Food Chem Toxicol. 50:295–302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elumalai P, Gunadharini DN, Senthilkumar
K, Banudevi S, Arunkumar R, Benson CS, Sharmila G and Arunakaran J:
Induction of apoptosis in human breast cancer cells by nimbolide
through extrinsic and intrinsic pathway. Toxicol Lett. 215:131–142.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li P, Tian W and Ma X: Alpha-mangostin
inhibits intracellular fatty acid synthase and induces apoptosis in
breast cancer cells. Mol Cancer. 13:1382014. View Article : Google Scholar : PubMed/NCBI
|
